Senior Director Product and Portfolio Strategy
Glaxosmithkline
Site Name: UK – London – New Oxford Street, Belgium-Wavre, Philadelphia Walnut Street, USA - Massachusetts - Boston Posted Date: Feb 5 2025 Senior Director Product and Portfolio Strategy As a Senior Director, Global Product and Portfolio Strategy, you will play a strategic role and be a key member of the Global Vaccines Commercial and Portfolio Strategy Team. This position reports to the Vice President Commercial and Portfolio Strategy within the broader Vaccines Global Product Strategy organization. Location is to be at one of the major GSK sites; Wavre, London, Philadelphia or Boston, with some flexibility in Europe or East Coast US on locations for the right candidate. In this role, you need to bring exceptional strategic thinking and leadership skills, with the ability to synthesize complex and diverse information to craft clear, actionable strategic imperative that will drive long-term value for the Vaccines portfolio. You will use your expertise with business-strategy development, business case generation, asset valuation and associated analytics and intelligence methodologies to ensure that we are designing and executing optimal commercial strategies for our products to add value to our portfolio. You will synthesize large amounts of data from multiple domains and translate this into a cogent analysis that leads to recommendations that will shape the future of our Vaccines business. Spanning science, medical practice, competitive intelligence, strategy, marketing, corporate finance and early-stage investment, you will be responsible for using business cases to ensure alignment between key strategic levers e.g. the target vaccine profile (TVP), key claims, clinical development plans (CDP) and major internal and external risks, opportunities and uncertainties for our portfolio and target external assets. In the role you will influence portfolio strategy development, proposing investments, both internal and external. You will be a key member of the teams that are responsible for product and strategy development, for championing investment projects and presenting the associated investment proposals at the Vaccines Research Unit Board, the Financial Review Committee (FRC) Pharma Investment Board (PIB). From an asset perspective, you will be accountable for asset and disease area strategy business cases of new assets, ensuring that the business cases and investment strategies accurately, transparently and fully reflect internal and external data, assumptions, ambiguities, risks and opportunities. You need to be fluent in the science behind the diseases and asserts, as well as having working knowledge of the development pathways to enable discussion and debate with relevant business partners, and to establish relationships with global key external experts and academic/community centers. In this role you will be expected to: At the Global Vaccines strategy level Contribute to the development of the Global Vaccines strategy via cross-functional collaboration Understand the macro factors affecting global vaccines market and scientific evolution Own and generate multifactorial analyses of the internal and external environments Give perspectives on the global vaccines market in significant detail and the levers that drive it Provide views on competitive forces and their relationship to GSK’s pursuit of its vaccines strategy Understand key competitor strategies, programmes, and investments and be able to articulate how these may shape the marketplace and our position in it Have a deep understanding of the US vaccines market dynamics and market access environment Develop actionable recommendations grounded in robust analysis, balancing immediate goals with long-term enterprise priorities Work positively with many functions around the organisation in both global and key country teams At the asset level Work closely with the Vice President, Commercial and Portfolio Strategy, to ensure alignment of asset-level strategies with broader portfolio objectives Critically evaluate the value and strategic alignment of programs under your/your team’s remit and have the courage to recommend the discontinuation of those that fail to deliver value or meet portfolio objectives Develop robust, evidence-based global market and asset forecasts and valuations for internal early pipeline vaccines as they progress through development milestones and governance decision points Collaborate with R&D and Medical to design and refine medical and commercial strategies that and ensure alignment of Target Vaccine Profile (TVP) and clinical development plans (CDP). Define, structure, plan and commission market research required to answer questions not already addressed through internal knowledge and experience and/or secondary data sources, ensure all market insight activities are conducted in an ethical way and according to relevant Codes of Conduct. Provide market landscapes and therapy area overviews and situation analyses to support strategy and trade off decisions associated with investment proposals (internal and external). Critical to the success of this role is an ability to demonstrate the value of strong commercial partnership with R&D, Manufacturing and Medical organizations, whilst championing the need for patient and payer focus during early development. Effectively engage with global external experts and academic/community centers and lead advisory boards to gather insights and inform strategies, and to support BD initiatives. Requirements Basic Qualifications/experience: We are looking for professionals with these required skills to achieve our goals: Minimum degree level Business, Finance, Health Economics, Marketing, Science or equivalent. Considerable experience in healthcare, in pharmaceutical (medical or marketing background), management consultancy or financial institution. Experience of contributing to the development of product and/or portfolio strategies by analyzing complex data, identifying key insights, and supporting the alignment of cross-functional stakeholders around actionable recommendations. Proven application of high-quality strategic analytics and ability to provide insightful commercial and market analytics and intelligence. Proven ability in asset and portfolio forecasting and valuation. Demonstrate fluency in immunology, vaccinology, and related scientific disciplines, with the ability to engage meaningfully with R&D, Medical, and external scientific experts. Thorough understanding of the drug development and commercialization process. Experienced in a global matrix environment, able to drive impact across a range of functions, seniority, and geographical locations. Ability to lead the delivery of projects from end to end and take ownership and accountability for the deliverables. A proactive and strategic thinker who can work as a solo team member and also inspire, motivate, and influence diverse teams that are not direct reports. Act as a catalyst for change through strong business partnering. Ability to see the big picture and effectively prioritize short- and long-term objectives. Ability to challenge senior stakeholders and ask the right questions to achieve the optimal outcome. Excellent negotiation, decision making and problem-solving skills. Preferred Qualifications/experience: MBA, PhD, MD preferred - postgraduate degrees in medicine and/or science and business/strategy. Field Experience, e.g. Sales, Market Access, MSL etc. Proven track record of developing and implementing clear, product and/or portfolio strategies that have been endorsed by senior leadership and demonstrate the balancing of long and short-term priorities. Previous regional/global function and experience in major organization. Substantial experience working in early and late-stage product development. Experience in building and maintaining collaborative partnerships with internal medical organisations and Key External Experts (KEEs) and bringing key inputs into strategic analyses. Management experience leading commercial function(s) within the US and/or other key countries like Germany, China or Japan. Equity analyst experience with investment bank and/or PE or VC investment experience (deal origination etc.) or medical scientist with investment decision experience in R&D. Corporate/BU/TA Strategy development experience. Diverse Life-science commercial background including insight work. Closing Date for Applications: 15th February 2025 (EOD) Please take a copy of the Job Description, as this will not be available post closure of the advert. When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application. Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together. As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only). We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are. Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on Ukdiversity.recruitment@gsk.com or 0808 234 4391. The helpline is available from 8.30am to 12.00 noon Monday to Friday, during bank holidays these times and days may vary. Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a UK Recruitment FAQ guide. Click the link and scroll to the Careers Section where you will find answers to multiple questions we receive . As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially. Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site. Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/
Confirm your E-mail: Send Email
All Jobs from Glaxosmithkline